• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular perspectives on stem cell transplant and Car-T cell therapy: The old and the new for assessment and management.

作者信息

Rao Anjali, Zaha Vlad G

机构信息

Department of Internal Medicine, Cardiology Division, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Parkland Health and Hospital System, Dallas, TX, USA.

出版信息

Am Heart J Plus. 2022 Aug 24;22:100198. doi: 10.1016/j.ahjo.2022.100198. eCollection 2022 Oct.

DOI:10.1016/j.ahjo.2022.100198
PMID:38558902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10978411/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f0/10978411/839eb530454d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f0/10978411/839eb530454d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f0/10978411/839eb530454d/gr1.jpg

相似文献

1
Cardiovascular perspectives on stem cell transplant and Car-T cell therapy: The old and the new for assessment and management.干细胞移植和嵌合抗原受体T细胞疗法的心血管视角：评估与管理中的新旧问题
Am Heart J Plus. 2022 Aug 24;22:100198. doi: 10.1016/j.ahjo.2022.100198. eCollection 2022 Oct.
2
Immunotherapies Old and New: Hematopoietic Stem Cell Transplant, Chimeric Antigen Receptor T Cells, and Bispecific Antibodies for the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma.新旧免疫疗法：造血干细胞移植、嵌合抗原受体 T 细胞和双特异性抗体治疗复发/难治性弥漫性大 B 细胞淋巴瘤。
Curr Hematol Malig Rep. 2021 Feb;16(1):72-81. doi: 10.1007/s11899-021-00610-y. Epub 2021 Feb 22.
3
In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia.自杀基因修饰的抗CD33重定向嵌合抗原受体T细胞用于急性髓系白血病的体外临床前验证
PLoS One. 2016 Dec 1;11(12):e0166891. doi: 10.1371/journal.pone.0166891. eCollection 2016.
4
Allogeneic CD34 selected hematopoietic stem cell boost following CAR T-cell therapy in a patient with prolonged cytopenia and active infection.患者因血细胞减少症持续存在和活动性感染而接受 CAR T 细胞治疗后，进行同种异体 CD34 选择造血干细胞增强。
Pediatr Blood Cancer. 2023 Mar;70(3):e30166. doi: 10.1002/pbc.30166. Epub 2022 Dec 24.
5
How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?如何将两种标志性治疗方法——异体造血干细胞移植和嵌合抗原受体 T 细胞疗法相结合，治愈高危 B 细胞急性淋巴细胞白血病？
Front Immunol. 2020 Dec 15;11:611710. doi: 10.3389/fimmu.2020.611710. eCollection 2020.
6
Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study.移植前微小残留病灶阴性预测 CAR-T 治疗后行单倍体相合造血干细胞移植治疗复发/难治性急性淋巴细胞白血病的良好结局：一项多中心回顾性研究。
J Hematol Oncol. 2020 May 4;13(1):42. doi: 10.1186/s13045-020-00873-7.
7
Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant.供者造血干细胞/淋巴细胞维持治疗在干细胞移植后复发的 B 细胞急性淋巴细胞白血病患者 CAR T 细胞治疗后。
Cell Transplant. 2023 Jan-Dec;32:9636897231158155. doi: 10.1177/09636897231158155.
8
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.澳大利亚和新西兰移植和细胞治疗学会（ANZTCT）立场声明：造血干细胞移植和嵌合抗原受体 T 细胞患者的 COVID-19 管理。
Intern Med J. 2023 Jan;53(1):119-125. doi: 10.1111/imj.15978.
9
The pharmacist's role in chimeric antigen receptor T cell therapy.药剂师在嵌合抗原受体T细胞疗法中的作用。
J Oncol Pharm Pract. 2020 Oct;26(7):1725-1731. doi: 10.1177/1078155220948940. Epub 2020 Aug 20.
10
Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions.B 急性淋巴细胞白血病中的嵌合抗原受体 T 细胞：现状与未来方向
Front Oncol. 2020 Aug 26;10:1594. doi: 10.3389/fonc.2020.01594. eCollection 2020.

本文引用的文献

1
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.异体血液或骨髓移植后 40 余年的晚期死亡率和预期寿命趋势：一项血液或骨髓移植存活者研究报告。
JAMA Oncol. 2021 Nov 1;7(11):1626-1634. doi: 10.1001/jamaoncol.2021.3676.
2
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide.基于来那度胺调控的可逆转 ON/OFF 开关嵌合抗原受体
Sci Transl Med. 2021 Jan 6;13(575). doi: 10.1126/scitranslmed.abb6295.
3
Usefulness of Stress Echocardiography in the Management of Patients Treated with Anticancer Drugs.
在癌症药物治疗患者管理中，应激超声心动图的作用。
J Am Soc Echocardiogr. 2021 Feb;34(2):107-116. doi: 10.1016/j.echo.2020.10.002. Epub 2020 Nov 19.
4
Chimeric Antigen Receptor T-Cell Therapy-Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma.难治性或复发性非霍奇金淋巴瘤患者中与嵌合抗原受体T细胞疗法相关的心肌病
Circulation. 2020 Oct 27;142(17):1687-1690. doi: 10.1161/CIRCULATIONAHA.120.048100. Epub 2020 Oct 26.
5
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines.心血管毒性与癌症治疗相关：对美国和欧洲心血管肿瘤学指南的务实方法。
J Am Heart Assoc. 2020 Sep 15;9(18):e018403. doi: 10.1161/JAHA.120.018403. Epub 2020 Sep 5.
6
Cardiovascular Effects of CAR T Cell Therapy: A Retrospective Study.嵌合抗原受体T细胞疗法的心血管效应：一项回顾性研究
JACC CardioOncol. 2020 Jun;2(2):193-203. doi: 10.1016/j.jaccao.2020.04.012. Epub 2020 Jun 16.
7
Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease.评估疑似冠心病患者的应激心脏磁共振成像在风险再分类中的作用。
JAMA Cardiol. 2020 Dec 1;5(12):1401-1409. doi: 10.1001/jamacardio.2020.2834.
8
Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies.新兴癌症治疗时代的多模态心脏成像
J Am Heart Assoc. 2020 Jan 21;9(2):e013755. doi: 10.1161/JAHA.119.013755.
9
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives.嵌合抗原受体 T 细胞疗法治疗癌症和心脏：JACC 理事会观点。
J Am Coll Cardiol. 2019 Dec 24;74(25):3153-3163. doi: 10.1016/j.jacc.2019.10.049.
10
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T).嵌合抗原受体 T 细胞（CAR-T）治疗的成年人中的心血管事件。
J Am Coll Cardiol. 2019 Dec 24;74(25):3099-3108. doi: 10.1016/j.jacc.2019.10.038.